Sabitlenmiş Tweet
SYNAPSE R&D Managers
1.9K posts

SYNAPSE R&D Managers
@SynapseManagers
Experts in managing R&D biomed projects providing practical support and strategic guidance to scientific coordinators throughout the whole project life cycle.
Barcelona, Spain Katılım Mart 2016
413 Takip Edilen334 Takipçiler
SYNAPSE R&D Managers retweetledi

Our Innovative Health Initiative (IHI) funded @IHI_PROMINENT project kicks off 2026 with continued progress across all teams. Find out about our latest activities:
ihi-prominent.eu/prominent-proj…
English
SYNAPSE R&D Managers retweetledi

🚨NEW paper published in Alzheimer's & Dementia investigating the diagnostic accuracy and clinical utility of key Alzheiemer's disease-related plasma biomarkers.
Congratulations to all authors👏
@IHIEurope @goteborgsuni @IHI_PROMINENT
Check it out⤵️
alz-journals.onlinelibrary.wiley.com/doi/10.1002/al…
English
SYNAPSE R&D Managers retweetledi

Helmholtz Munich Launches Pioneering Osteoarthritis Research Project With EU Partners
👉t1p.de/64zie
#HelmholtzMunich is part of #PROBE, a new EU-funded initiative aiming to transform how #osteoarthritis is diagnosed and treated. The project is supported by Horizon Europe through the Innovative Health Initiative and has a total budget of €26 million – €1.4 million of which is allocated to Helmholtz Munich.
🧬 Building the foundation for #PersonalizedMedicine
Osteoarthritis affects more than 500 million people worldwide. PROBE will integrate data from over 70 million individuals – enabling AI-driven analyses, predictive models, and innovative clinical study designs that pave the way for more precise diagnostics and tailored therapies.
🔍 Accelerating clinical impact
The consortium of 38 partners brings together expertise in #AI, data protection and ethics. The project aims to establish innovative endpoints, enhance therapy evaluation, and support shared decision-making for patients and clinicians.
💬 “With PROBE, we are uniting expertise and data across Europe to take osteoarthritis research to the next level. AI-powered analyses of federated multimodal data at unprecedented scale provide the foundation for personalized therapies and more efficient clinical trials – all with the clear goal of sustainably improving the quality of life for the hundreds of millions of people affected.”
– Prof. Eleftheria Zeggini, who leads Helmholtz Munich’s contribution to PROBE
@EleZeggini @fabian_theis @ja_schnabel @heinig_matthias @CompHealthMuc @HorizonEU @Novartis
#Osteoarthritis #AIinHealth #HorizonEU #OA #BigData

English

📢 We're excited to announce the official launch of
PROBE 👏
#PROBE is a pioneering initiative set to transform #osteoarthritis care through federated data and #AI-driven clinical innovation.
Learn more:
👉ihi-probe.eu

English

According to official data from @CDTI_innovacion , SYNAPSE ranks among the Spanish organisations with the highest financial return from participation in Innovative Health Initiative (IHI) projects, alongside leading academic and healthcare institutions 👏
eventos.cdti.es/agenda/Jornada…

English
SYNAPSE R&D Managers retweetledi

🚨The SUSTAIN-HS Tool
An interactive platform for HTA stakeholders to track & share emerging methodological needs.
🗺️Map needs across Europe
🔍Contribute new methodological needs
📄Access reports
🔗Read more: sustain-hta.org/2025/10/06/int…
#SUSTAIN_HTA #HorizonEurope #HTA
English
SYNAPSE R&D Managers retweetledi

Working in an HTA body? We want to hear from you!
The SUSTAIN-HTA consortium is conducting a survey on the methodological needs of HTA organisations.
Your input will help shape the future of HTA methods.
Take the survey here: survey.uu.nl/jfe/form/SV_6s…
#SUSTAIN_HTA #HorizonEurope

English

One year of #VICT3R in the books!
We’re excited to share a look back at the communication and dissemination highlights from the first 12 months of the project👏
More information:
👉 vict3r.eu
#Toxicology #AnimalWelfare #EthicalResearch #AI
English
SYNAPSE R&D Managers retweetledi

💡Did you know that in 2021 about 57 million people were living with #dementia worldwide?
🧠Alzheimer's disease is the most common type of dementia and may contribute to 60–70% of cases.
📖who.int/news-room/fact…
#YourBrainMatters #BrainHealth #WAM2025 #WorldAlzMonth
English

Today is #WorldAlzheimersDay 🧠
For over a decade, we’ve supported research into dementia, Alzheimer’s disease and neurodegenerative conditions, contributing to ambitious, impactful projects
👉 synapse-managers.com/library/2025/2…
#WorldAlzheimersMonth #AskAboutDementia #AskAboutAlzheimers
English
SYNAPSE R&D Managers retweetledi

🌍Today on #WorldAlzheimersDay, we’re sharing an inspiring interview with Trevor Salomon, Chairperson of the European Dementia Carers Working Group #EDCWG
➡️Read his interview on our website:
ad-riddle.org/resources/worl…
@AlzheimerEurope #LoveYourBrain #WAM2025 #WorldAlzMonth

English
SYNAPSE R&D Managers retweetledi

🌍Today, on #WorldAlzheimersDay, we share @AD_RIDDLE stories from our Advisory Board - real experiences in #dementia prevention, risk reduction & #BrainHealth.
Read more on our website ➡️ad-riddle.org/resources/worl…
#LoveYourBrain #YourBrainMatters #WAM2025 #WorldAlzMonth


English

We're proud to share that we have contributed to three impactful scientific publications so far in 2025, underlining our commitment to advancing real-world data, AI, and data-driven research 🔬
Learn more here:
👉 synapse-managers.com/library/2025/1…
#RWD #AI #HealthResearch

English
SYNAPSE R&D Managers retweetledi

“AI has to work in real life.” PROMINENT co-develops with people living with dementia & care partners, builds a digital decision-support platform for Alzheimer’s & sets up real-world evidence to monitor & evaluate new treatments in routine care. @0xbnd #WAM2025 #WorldAlzhMonth
English
SYNAPSE R&D Managers retweetledi

💡Did you know that what’s good for your heart is also good for your brain?
FINGER model: simultaneous lifestyle measures in 5 areas can help prevent and delay the development of cognitive decline➡️ fbhi.se/the-finger-mod…
#YourBrainMatters #BrainHealth #WAM2025 #WorldAlzMonth
English
SYNAPSE R&D Managers retweetledi

#WorldAlzheimersMonth: Research must reflect lived experience. In the PROMINENT project, people affected by dementia help design a digital decision-support platform to help clinicians make individualised & evidence-based decisions.
Learn more: ihi-prominent.eu
English
SYNAPSE R&D Managers retweetledi

💡Did you know? Up to 45% of dementia cases could potentially be delayed or reduced by addressing 14 modifiable risk factors throughout life⤵️
thelancet.com/commissions-do…
#LoveYourBrain #YourBrainMatters #BrainHealth #WAM2025 #WorldAlzMonth
English

Today is #WorldBrainDay 🧠
A global initiative to raise awareness of the importance of safeguarding brain health. At SYNAPSE, we're proud to support this through projects like @AD_RIDDLE, CLAIMS, @imi_epnd and @IHI_PROMINENT
#WBD2025 #BrainHealthForAllAges

English